Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | GARVA MEDICAL AGENCY | 1 | ₹1.5 L |
| 2 | Schedule 2 | MEDION BIOTECH PRIVATE LIMITED | 1 | ₹126 |
| 3 | Schedule 5 | ARORA BROS MEDILINKERS | 4 | ₹37,709 |
| 4 | Schedule 8 | MEDIKON INDIA PRIVATE LIMITED | 1 | ₹22.2 L |
| 5 | Schedule 9 | MEDION BIOTECH PRIVATE LIMITED | 2 | ₹2,268 |
Tender Value
₹12.9 L
EMD Value
Exempted
Closing Date
27 Jul 2026, 11:00 amClosed
ECHS RE 17
9537830
GEM/2026/B/7726074
Two Packet Bid
Tab Temozolamide 140 mg,Tab Tamoxifen 20 mg,Tab Paclitaxel 110 mg,Inj Carboplatin 150 mg,Inj Degare
Hisar, Haryana
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹6 L
₹49 L
30%
Exempted
Yes
18 Jul 2026
8 Jul 2026
27 Jul 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Tab Temozolamide 140 mg | 90 | No | HISSAR | 21 |
| 2 | Tab Tamoxifen 20 mg | 90 | No | HISSAR | 21 |
| 3 | Tab Paclitaxel 110 mg | 4 | No | HISSAR | 21 |
| 4 | Inj Carboplatin 150 mg | 4 | No | HISSAR | 21 |
| 5 | Inj Degarelix 80mg | 7 | No | HISSAR | 21 |
| 6 | Inj Cisplatin 40 mg | 10 | No | HISSAR | 21 |
| 7 | Tab Valacyclovir 500 mg | 180 | No | HISSAR | 21 |
| 8 | Tab Niraparib 100 mg | 270 | No | HISSAR | 21 |
| 9 | Inj Sunitinib 25 mg | 90 | No | HISSAR | 21 |
| 10 | Tab Letrozole 2 Point 5 mg | 90 | No | HISSAR | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9537830.pdf
GEM_BID • 0.22 MB
item_2026-06-30-13-53-10_dd1bbdd3ad2bac5f5eadc15ede1b9278.pdf
BOQ • 0.18 MB
boq_item_sample_file_-18_2026-06-30-13-53-10_d6ac5ffaefad3dd05c372ae5be2e9eda.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .